Dr. Geoffrey Shapiro on the Role of CDK2 in Multiple Breast Cancer Types
January 26th 2016Geoffrey Shapiro, MD, PhD, director, Early Drug Development Center, Dana Farber, discusses the role of cyclin-dependent kinase (CDK4) in some breast cancer subtypes and the lack of targeted agents in triple-negative breast cancer.